Establishing the Quantitative Relationship Between Lanreotide Autogel®, Chromogranin A, and Progression-Free Survival in Patients with Nonfunctioning Gastroenteropancreatic Neuroendocrine Tumors
Journal Title: The AAPS Journal - Year 2016, Vol 18, Issue 3
Abstract
The online version of this article (doi:10.1208/s12248-016-9884-3) contains supplementary material, which is available to authorized users.
Authors and Affiliations
Núria Buil-Bruna, Marion Dehez, Amandine Manon, Thi Xuan Quyen Nguyen, Iñaki F. Trocóniz
Keywords
Related Articles
- EP ID EP680878
- DOI 10.1208/s12248-016-9884-3
- Views 47
- Downloads 0
BDDCS Applied to Over 900 Drugs
The online version of this article (doi:10.1208/s12248-011-9290-9) contains supplementary material, which is available to authorized users.
Comparison of the formulation requirements of dosator and dosing disc automatic capsule filling machines
The overall objective of this study was to provide ‘semi-quantitative’ or ‘rigorous’ definitions of the fluidity, lubricity and compactibility requirements of formulation for representativ...
When Assay Format Matters: a Case Study on the Evaluation of Three Assay Formats to Support a Clinical Pharmacokinetic Study
Data generated using various immunoassay methods are an integral part of the development of protein therapeutics. These assays are used in clinical and preclinical studies to establish the pharmacokinetic (PK) and pharma...
Synthesis, Spectral Characterization, and In Vitro Cellular Activities of Metapristone, a Potential Cancer Metastatic Chemopreventive Agent Derived from Mifepristone (RU486)
Mifepristone (RU486) is marketed and used widely by women as an abortifacient, and experimentally for psychotic depression and anticancer treatments. After administration, metapristone is found to be the most predominant...
Pharmacogenomics: The promise of personalized medicine